Correlation Between Canopus BioPharma and International Consolidated
Can any of the company-specific risk be diversified away by investing in both Canopus BioPharma and International Consolidated at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Canopus BioPharma and International Consolidated into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Canopus BioPharma Incorporated and International Consolidated Companies, you can compare the effects of market volatilities on Canopus BioPharma and International Consolidated and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Canopus BioPharma with a short position of International Consolidated. Check out your portfolio center. Please also check ongoing floating volatility patterns of Canopus BioPharma and International Consolidated.
Diversification Opportunities for Canopus BioPharma and International Consolidated
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Canopus and International is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Canopus BioPharma Incorporated and International Consolidated Com in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on International Consolidated and Canopus BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Canopus BioPharma Incorporated are associated (or correlated) with International Consolidated. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of International Consolidated has no effect on the direction of Canopus BioPharma i.e., Canopus BioPharma and International Consolidated go up and down completely randomly.
Pair Corralation between Canopus BioPharma and International Consolidated
Given the investment horizon of 90 days Canopus BioPharma is expected to generate 18.53 times less return on investment than International Consolidated. But when comparing it to its historical volatility, Canopus BioPharma Incorporated is 7.29 times less risky than International Consolidated. It trades about 0.11 of its potential returns per unit of risk. International Consolidated Companies is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest 40.00 in International Consolidated Companies on October 16, 2024 and sell it today you would lose (36.25) from holding International Consolidated Companies or give up 90.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Canopus BioPharma Incorporated vs. International Consolidated Com
Performance |
| Timeline |
| Canopus BioPharma |
| International Consolidated |
Canopus BioPharma and International Consolidated Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Canopus BioPharma and International Consolidated
The main advantage of trading using opposite Canopus BioPharma and International Consolidated positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Canopus BioPharma position performs unexpectedly, International Consolidated can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Consolidated will offset losses from the drop in International Consolidated's long position.| Canopus BioPharma vs. International Consolidated Companies | Canopus BioPharma vs. Frontera Group | Canopus BioPharma vs. XCPCNL Business Services | Canopus BioPharma vs. Aramark Holdings |
| International Consolidated vs. Frontera Group | International Consolidated vs. All American Pet | International Consolidated vs. XCPCNL Business Services | International Consolidated vs. Aramark Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |